U.S. health systems are rolling out branded chatbots to compete with the large language models many Americans already use for medical advice, according to arstechnica.com.
These new tools aim to capture patients by integrating directly into existing medical infrastructures. Some providers are even launching dedicated platforms to steer users toward their specific clinical services.
K Health, a clinical AI company, is currently working with Hartford HealthCare in Connecticut to deploy its PatientGPT chatbot to tens of thousands of patients. The initiative seeks to bridge the gap between digital queries and professional care.
"We are at an inflection point in healthcare," Allon Bloch, CEO of K Health, said in a statement. "Demand is accelerating, and patients are already using AI to navigate their lives."
Bloch added that the goal is to provide a safe, transparent way to use AI within a system connected to medical records. "PatientGPT represents that turning point," he said.
Risks and clinical uncertainty
Hospital executives frame these chatbots as a way to improve digital equity and meet patients where they already spend time online. They argue that branded medical bots are safer alternatives to the generic commercial models currently available to the public.
However, medical experts warn that the clinical benefits of these tools remain unproven. Adam Rodman, an internist and clinical reasoning researcher at Beth Israel Deaconess Medical Center, told Stat News that there is no evidence yet that integrating chatbots into health systems improves patient outcomes.
"It’s a tempting idea," Rodman said. "We’re not there yet."
Skeptics also point to several unresolved hurdles in the rollout of medical AI. These include potential issues with liability, the necessity of constant monitoring, and whether these tools actually address the underlying problems in the American healthcare system.